This is an archived article that was published on sltrib.com in 2013, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.
WASHINGTON • Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate.
The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back prostate tissue that presses against the urethra, causing difficulty urinating.
More than half of men in their sixties have some urinary problems due to enlarged prostate, including frequent urination, weak stream and leaking. Current treatment options include drug therapy and surgery to remove part of the prostate. The Urolift is implanted by a doctor using a handheld device that is inserted through the urethra.
Side effects reported in company trials include pain during urination, blood in urine and decreased urine flow.